The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer | Zendy

Mustafa Gürbüz | Zendy; İzzet Doğan | Zendy; Erman Akkuş | Zendy; Hilal Özakıncı | Zendy; Pınar Kubilay Tolunay | Zendy; Ender Kalacı | Zendy; Tolga Bağlan | Zendy; Elif Berna Köksoy | Zendy; Koray Ceyhan | Zendy; Serpil Dızbay Sak | Zendy; Adnan Aydınder | Zendy; Ahmet Demirkazık | Zendy; Güngör Utkan | Zendy

Open Access

The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer

Author(s) -

Mustafa Gürbüz,

İzzet Doğan,

Erman Akkuş,

Hilal Özakıncı,

Pınar Kubilay Tolunay,

Ender Kalacı,

Tolga Bağlan,

Elif Berna Köksoy,

Koray Ceyhan,

Serpil Dızbay Sak,

Adnan Aydınder,

Ahmet Demirkazık,

Güngör Utkan

Publication year - 2022

Publication title -

tuberkuloz ve toraks

Language(s) - English

Resource type - Journals

ISSN - 0494-1373

DOI - 10.5578/tt.20229803

Subject(s) - medicine , lung cancer , adenocarcinoma , stage (stratigraphy) , oncology , cancer , gastroenterology , pd l1 , immunohistochemistry , pathology , biology , immunotherapy , paleontology

Clinicopathological parameters related to programmed death ligand 1 (PD-L1) expression levels have been investigated in several studies. However, the results of these studies are conflicting and vary in different populations. This study aimed to investigate the relation of clinicopathological parameters with PD-L1 expression level in advanced stage non-small cell lung cancer patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research